Bio Path reported $8K in Ordinary Share Capital for its fiscal quarter ending in March of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Baxter International USD 514.28M 168.72M Dec/2025
Bio Path USD 8K 2K Mar/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 93.54M 3.99M Jun/2025
CSL USD 482.13M 93.87M Dec/2025
Grifols EUR 679.73M 0 Sep/2025
Karyopharm Therapeutics USD 13K 0 Sep/2024